LeonaBio, Inc.
General ticker "LONA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $90.8M (TTM average)
LeonaBio, Inc. follows the US Stock Market performance with the rate: 9.2%.
Estimated limits based on current volatility of 5.1%: low 4.27$, high 4.74$
Factors to consider:
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.83$, 12.04$]
- 2026-12-31 to 2027-12-31 estimated range: [2.18$, 7.40$]
Financial Metrics affecting the LONA estimates:
- Negative: with PPE of -0.3 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Operating cash flow
- Negative: Investing cash flow per share per price, % of -50.34 <= -39.19
- Negative: 24.07 < Shareholder equity ratio, % of 30.16 <= 33.49
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
Short-term LONA quotes
Long-term LONA plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM |
| Operating Expenses | $100.90MM | $102.27MM |
| Operating Income | $-100.90MM | $-102.27MM |
| Non-Operating Income | $3.96MM | $-3.34MM |
| R&D Expense | $70.68MM | $17.50MM |
| Income(Loss) | $-96.94MM | $-105.61MM |
| Net Income(Loss)* | $-96.94MM | $-105.61MM |
| Stockholders Equity | $44.84MM | $27.79MM |
| Assets | $58.78MM | $92.15MM |
| Operating Cash Flow | $-97.17MM | $-45.73MM |
| Capital expenditure | $0.03MM | $0.00MM |
| Investing Cash Flow | $54.83MM | $-15.89MM |
| Financing Cash Flow | $0.19MM | $82.46MM |
| Earnings Per Share** | $-25.19 | $-24.70 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.